{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:59:00Z","timestamp":1793901540497,"version":"4.8.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bundibugyo ebolavirus (BDBV) is a rare filovirus species with an estimated case fatality rate (CFR) ranging from 25% to 51%. The 2026 BDBV outbreak in the Democratic Republic of the Congo (DRC) was declared a Public Health Emergency of International Concern (PHEIC), highlighting the critical necessity of assessing global research preparedness for this pathogen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To systematically map the global scientific evidence base on BDBV, characterize temporal and thematic publication trends, identify critical knowledge gaps, and formulate actionable priorities for public health response and clinical research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA-ScR guidelines, we programmatically searched PubMed\/MEDLINE, OpenAlex, and Semantic Scholar for literature published from 2007 through May 2026. From 4,379 screened records, 100 high-relevance studies were selected using a weighted composite relevance scoring system. To structure the evidence, we synthesized a novel conceptual model mapping BDBV research across three core pillars\u2014epidemiological drivers, health system responses, and public health outcomes\u2014connected by a policy feedback loop and conditioned by cross-cutting systemic moderators (conflict, weak infrastructure, global governance, and research gaps). Methodological quality was evaluated using the Risk of Bias 2.0 (RoB 2) framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only 23% of the included studies specifically addressed BDBV, with the remainder focusing on broader ebolavirus topics dominated by Ebola virus (EBOV). Applying the conceptual model revealed pronounced asymmetries across the research domains: the literature remains heavily concentrated within upstream epidemiological drivers and clinical features. Conversely, critical health system response domains lack validated tools; no licensed vaccine, specific therapeutic agent, or point-of-care rapid diagnostic test validated for BDBV currently exists. While cross-reactive monoclonal antibodies show preclinical efficacy, clinical-grade validation remains absent, and longitudinal survivor outcomes are sparsely documented. Systemic moderators, particularly weak health infrastructure and conflict, continue to compound these gaps. Methodological risk of bias was moderate, driven by missing outcome data (42% of studies) and selective reporting (41%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BDBV remains understudied relative to its epidemic potential. Sustained, internationally coordinated investments modeled on prior EBOV frameworks are required to transition from reactive to proactive research models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13977-1","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:47:10Z","timestamp":1783579630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the global evidence base of bundibugyo ebolavirus disease: a systematic scoping review of research gaps and preparedness priorities"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5919-4361","authenticated-orcid":false,"given":"Abigail","family":"Boatemaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8523-568X","authenticated-orcid":false,"given":"Baffour","family":"Osei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-8066","authenticated-orcid":false,"given":"Gabriel Osei","family":"Forkuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"13977_CR1","doi-asserted-by":"publisher","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","volume":"4","author":"JS Towner","year":"2008","unstructured":"Towner JS, Sealy TK, Khristova ML, Albari\u00f1o CG, Conlan S, Reeder SA, et al. Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda. PLoS Pathog. 2008;4:e1000212. https:\/\/doi.org\/10.1371\/journal.ppat.1000212.","journal-title":"PLoS Pathog"},{"key":"13977_CR2","doi-asserted-by":"publisher","first-page":"105851","DOI":"10.1016\/j.antiviral.2024.105851","volume":"225","author":"J Felgner","year":"2024","unstructured":"Felgner J, Clarke E, Hernandez-Davies JE, Jan S, Wirchnianski AS, Jain A, et al. Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines. Antiviral Res. 2024;225:105851. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105851","journal-title":"Antiviral Res"},{"key":"13977_CR3","doi-asserted-by":"publisher","first-page":"S660","DOI":"10.1093\/infdis\/jiad157","volume":"228","author":"C Woolsey","year":"2023","unstructured":"Woolsey C, Borisevich V, Agans KN, O\u2019Toole R, Fenton KA, Harrison MB, et al. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus. J Infect Dis. 2023;228:S660\u201370. https:\/\/doi.org\/10.1093\/infdis\/jiad157.","journal-title":"J Infect Dis"},{"key":"13977_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virol.2011.11.027","volume":"423","author":"M Gupta","year":"2012","unstructured":"Gupta M, MacNeil A, Reed ZD, Rollin PE, Spiropoulou CF. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus. Virology. 2012;423:119\u201324. https:\/\/doi.org\/10.1016\/j.virol.2011.11.027.","journal-title":"Virology"},{"key":"13977_CR5","doi-asserted-by":"publisher","first-page":"e52986","DOI":"10.1371\/journal.pone.0052986","volume":"7","author":"P Roddy","year":"2012","unstructured":"Roddy P, Howard N, Van Kerkhove MD, Lutwama J, Wamala J, Yoti Z, et al. Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007\u20132008. PLoS ONE. 2012;7:e52986. https:\/\/doi.org\/10.1371\/journal.pone.0052986.","journal-title":"PLoS ONE"},{"key":"13977_CR6","doi-asserted-by":"publisher","first-page":"100351","DOI":"10.1016\/j.xcrm.2021.100351","volume":"2","author":"CE Hulseberg","year":"2021","unstructured":"Hulseberg CE, Kumar R, Di Paola N, Larson P, Nagle ER, Richardson J, et al. Molecular analysis of the 2012 Bundibugyo virus disease outbreak. Cell Rep Med. 2021;2:100351. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100351.","journal-title":"Cell Rep Med"},{"key":"13977_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.virol.2013.04.014","volume":"442","author":"CG Albari\u00f1o","year":"2013","unstructured":"Albari\u00f1o CG, Shoemaker T, Khristova ML, Wamala JF, Muyembe JJ, Balinandi S, et al. Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virology. 2013;442:97\u2013100. https:\/\/doi.org\/10.1016\/j.virol.2013.04.014.","journal-title":"Virology"},{"key":"13977_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jiph.2023.10.020","volume":"17","author":"J Izudi","year":"2024","unstructured":"Izudi J, Bajunirwe F. Case fatality rate for Ebola disease, 1976\u20132022: A meta-analysis of global data. J Infect Public Health. 2024;17:25\u201334. https:\/\/doi.org\/10.1016\/j.jiph.2023.10.020.","journal-title":"J Infect Public Health"},{"key":"13977_CR9","doi-asserted-by":"publisher","first-page":"e00643","DOI":"10.1128\/JVI.00643-21","volume":"95","author":"CB Levine","year":"2021","unstructured":"Levine CB, Mire CE, Geisbert TW. Comparison of Zaire and Bundibugyo Ebolavirus Polymerase Complexes and Susceptibility to Antivirals through a Newly Developed Bundibugyo Minigenome System. J Virol. 2021;95:e00643\u201321. https:\/\/doi.org\/10.1128\/JVI.00643-21.","journal-title":"J Virol"},{"key":"13977_CR10","doi-asserted-by":"publisher","unstructured":"Phelan AL, Nuzzo JB, Gostin LO. The PHEIC for Ebola disease caused by Bundibugyo virus: an inflection point for solidarity and health equity. Lancet. 2026. https:\/\/doi.org\/10.1016\/S0140-6736(26)01037-8.","DOI":"10.1016\/S0140-6736(26)01037-8"},{"key":"13977_CR11","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1038\/s41467-026-73746-1","volume":"17","author":"The current","year":"2026","unstructured":"The current Ebola outbreak is a public health emergency of international concern. Nat Commun. 2026;17:4603. https:\/\/doi.org\/10.1038\/s41467-026-73746-1.","journal-title":"Nat Commun"},{"key":"13977_CR12","doi-asserted-by":"publisher","unstructured":"Haider N, Khan RA, Rahman KM. Beyond past Ebola outbreaks: delayed detection, preparedness gaps, and the vaccine race during the 2026 Bundibugyo virus outbreak. Int J Infect Dis. 2026;108843. https:\/\/doi.org\/10.1016\/j.ijid.2026.108843.","DOI":"10.1016\/j.ijid.2026.108843"},{"key":"13977_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)01072-X","author":"D Mwamba","year":"2026","unstructured":"Mwamba D, Akilimali P, Mboussou F, Kabasubabo F, Angendu K, Ngandu C, et al. Bundibugyo virus disease outbreak in Ituri, Democratic Republic of the Congo. Lancet. 2026. https:\/\/doi.org\/10.1016\/S0140-6736(26)01072-X. S014067362601072X.","journal-title":"Lancet"},{"key":"13977_CR14","doi-asserted-by":"publisher","unstructured":"Velavan TP, Kremsner PG, Ntoumi F. Bundibugyo Ebola: why preparedness still fails at the point of detection. Lancet Infect Dis. 2026;S1473309926002860. https:\/\/doi.org\/10.1016\/S1473-3099(26)00286-0.","DOI":"10.1016\/S1473-3099(26)00286-0"},{"key":"13977_CR15","doi-asserted-by":"publisher","unstructured":"The Lancet Infectious Diseases. Key facts about the Bundibugyo virus outbreak. Lancet Infect Dis. 2026;S1473309926002938. https:\/\/doi.org\/10.1016\/S1473-3099(26)00293-8.","DOI":"10.1016\/S1473-3099(26)00293-8"},{"key":"13977_CR16","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41467-019-09732-7","volume":"10","author":"LB King","year":"2019","unstructured":"King LB, West BR, Moyer CL, Gilchuk P, Flyak A, Ilinykh PA, et al. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nat Commun. 2019;10:1788. https:\/\/doi.org\/10.1038\/s41467-019-09732-7.","journal-title":"Nat Commun"},{"key":"13977_CR17","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/infdis\/jiy453","volume":"218","author":"MS Bramble","year":"2018","unstructured":"Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, et al. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. J Infect Dis. 2018;218:1929\u201336. https:\/\/doi.org\/10.1093\/infdis\/jiy453","journal-title":"J Infect Dis"},{"key":"13977_CR18","doi-asserted-by":"publisher","first-page":"706757","DOI":"10.3389\/fimmu.2021.706757","volume":"12","author":"P Gilchuk","year":"2021","unstructured":"Gilchuk P, Guthals A, Bonissone SR, Shaw JB, Ilinykh PA, Huang K, et al. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Front Immunol. 2021;12:706757. https:\/\/doi.org\/10.3389\/fimmu.2021.706757.","journal-title":"Front Immunol"},{"key":"13977_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/82_2017_20","volume-title":"Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology","author":"RS Bennett","year":"2017","unstructured":"Bennett RS, Huzella LM, Jahrling PB, Bollinger L, Olinger GG, Hensley LE. Nonhuman Primate Models of Ebola Virus Disease. In: M\u00fchlberger E, Hensley LL, Towner JS, editors. Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology. Cham: Springer International Publishing; 2017. pp. 171\u201393. https:\/\/doi.org\/10.1007\/82_2017_20."},{"key":"13977_CR20","doi-asserted-by":"publisher","first-page":"101685","DOI":"10.1016\/j.nmni.2025.101685","volume":"69","author":"RE Kaweesa","year":"2026","unstructured":"Kaweesa RE, Katende JS, Wayesu RR, Ntabadde AD, Opio S, Kato L, et al. Resilience and residuals beyond containment \u2014 The hidden burden of Bundibugyo Ebola virus survivorship sixteen years on: A cross-sectional observational study. New Microbes New Infect. 2026;69:101685. https:\/\/doi.org\/10.1016\/j.nmni.2025.101685.","journal-title":"New Microbes New Infect"},{"key":"13977_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.08.24316967","author":"S Namusisi","year":"2024","unstructured":"Namusisi S, Waila JM, Hoffman SJ, Roberston C, Pelican K, Mahero M, Fear. Stigma and Uncertainty: The short and long-term effects of Ebola on survivors, affected families, and community in Bundibugyo. Western Uganda. 2024. https:\/\/doi.org\/10.1101\/2024.11.08.24316967.","journal-title":"Western Uganda"},{"key":"13977_CR22","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.celrep.2018.08.009","volume":"24","author":"CD Murin","year":"2018","unstructured":"Murin CD, Bruhn JF, Bornholdt ZA, Copps J, Stanfield R, Ward AB. Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop. Cell Rep. 2018;24:2723\u2013e27324. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.009.","journal-title":"Cell Rep"},{"key":"13977_CR23","doi-asserted-by":"publisher","first-page":"e01674","DOI":"10.1128\/mBio.01674-18","volume":"9","author":"BR West","year":"2018","unstructured":"West BR, Moyer CL, King LB, Fusco ML, Milligan JC, Hui S, et al. Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope. mBio. 2018;9:e01674\u201318. https:\/\/doi.org\/10.1128\/mBio.01674-18.","journal-title":"mBio"},{"key":"13977_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.34133\/research.1211","volume":"9","author":"X Zhang","year":"2026","unstructured":"Zhang X, Liu X, Zhou J, Gao P, Pan S, Yang X, et al. Computational Design of Broad-Spectrum Ebola Antibodies through Framework and Complementarity-Determining Region Synergistic Optimization. Research. 2026;9:1211. https:\/\/doi.org\/10.34133\/research.1211.","journal-title":"Research"},{"key":"13977_CR25","doi-asserted-by":"publisher","first-page":"2668755","DOI":"10.1080\/22221751.2026.2668755","volume":"15","author":"J Zhou","year":"2026","unstructured":"Zhou J, Zhang B, Yao Y, Li F, Chen S, Wu Y, et al. Engineered bispecific antibodies achieve broad and potent protection against multiple ebolavirus species. Emerg Microbes Infect. 2026;15:2668755. https:\/\/doi.org\/10.1080\/22221751.2026.2668755.","journal-title":"Emerg Microbes Infect"},{"key":"13977_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4236\/health.2019.111011","volume":"11","author":"C Kankya","year":"2019","unstructured":"Kankya C, Nabadda D, Kabonesa C, Nyakarahuka L, Muleme J, Okware S, et al. Social Dynamics of Ebola Virus Disease: A Case of Bundibugyo District, Uganda. Health. 2019;11:108\u201328. https:\/\/doi.org\/10.4236\/health.2019.111011.","journal-title":"Health"},{"key":"13977_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.11604\/pamj.2020.37.137.22957","volume":"37","author":"EA Mensah","year":"2020","unstructured":"Mensah EA, Kisakye A, Gyasi SO. Ebola virus disease surveillance in the absence of a confirmed case; the case of the Rwenzori region of Uganda. Pan Afr Med J. 2020;37:137. https:\/\/doi.org\/10.11604\/pamj.2020.37.137.22957.","journal-title":"Pan Afr Med J"},{"key":"13977_CR28","doi-asserted-by":"publisher","first-page":"S761","DOI":"10.1093\/infdis\/jir294","volume":"204","author":"A MacNeil","year":"2011","unstructured":"MacNeil A, Farnon EC, Morgan OW, Gould P, Boehmer TK, Blaney DD, et al. Filovirus Outbreak Detection and Surveillance: Lessons From Bundibugyo. J Infect Dis. 2011;204:S761\u20137. https:\/\/doi.org\/10.1093\/infdis\/jir294.","journal-title":"J Infect Dis"},{"key":"13977_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/v16081179","volume":"16","author":"Y Munyeku-Bazitama","year":"2024","unstructured":"Munyeku-Bazitama Y, Edidi-Atani F, Takada A. Non-Ebola Filoviruses: Potential Threats to Global Health Security. Viruses. 2024;16:1179. https:\/\/doi.org\/10.3390\/v16081179.","journal-title":"Viruses"},{"key":"13977_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4102\/ojvr.v79i2.451","volume":"79","author":"JJ Muyembe-Tamfum","year":"2012","unstructured":"Muyembe-Tamfum JJ, Mulangu S, Masumu J, Kayembe JM, Kemp A, Paweska JT. Ebola virus outbreaks in Africa: Past and present. Onderstepoort J Vet Res. 2012;79:451. https:\/\/doi.org\/10.4102\/ojvr.v79i2.451.","journal-title":"Onderstepoort J Vet Res"},{"key":"13977_CR31","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3201\/eid1607.091525","volume":"16","author":"JF Wamala","year":"2010","unstructured":"Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, et al. Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007\u20132008. Emerg Infect Dis. 2010;16:1087\u201392. https:\/\/doi.org\/10.3201\/eid1607.091525.","journal-title":"Emerg Infect Dis"},{"key":"13977_CR32","doi-asserted-by":"publisher","first-page":"e0129333","DOI":"10.1371\/journal.pone.0129333","volume":"10","author":"T Kratz","year":"2015","unstructured":"Kratz T, Roddy P, Tshomba Oloma A, Jeffs B, Pou Ciruelo D, De La Rosa O, et al. Ebola Virus Disease Outbreak in Isiro, Democratic Republic of the Congo, 2012: Signs and Symptoms, Management and Outcomes. PLoS ONE. 2015;10:e0129333. https:\/\/doi.org\/10.1371\/journal.pone.0129333.","journal-title":"PLoS ONE"},{"key":"13977_CR33","doi-asserted-by":"publisher","unstructured":"Choi B, Busch S, Kazadi D, Kebela B, Okitolonda E, Dai Y, et al. Modeling outbreak data: analysis of a 2012 Ebola virus disease epidemic in DRC. Biomath. 2019;8. https:\/\/doi.org\/10.11145\/j.biomath.2019.10.037.","DOI":"10.11145\/j.biomath.2019.10.037"},{"key":"13977_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.chom.2018.12.013","volume":"25","author":"A Patel","year":"2019","unstructured":"Patel A, Weiner DB. It Takes a Matured mAb to Treat Ebolavirus Infection. Cell Host Microbe. 2019;25:10\u20132. https:\/\/doi.org\/10.1016\/j.chom.2018.12.013.","journal-title":"Cell Host Microbe"},{"key":"13977_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy423","author":"OUP accepted manuscript","year":"2018","unstructured":"OUP accepted manuscript. J Infect Dis. 2018. https:\/\/doi.org\/10.1093\/infdis\/jiy423.","journal-title":"J Infect Dis"},{"key":"13977_CR36","doi-asserted-by":"publisher","first-page":"S648","DOI":"10.1093\/infdis\/jiad266","volume":"228","author":"DC Malherbe","year":"2023","unstructured":"Malherbe DC, Kimble JB, Atyeo C, Fischinger S, Meyer M, Cody SG, et al. A Single-Dose Intranasal Combination Panebolavirus Vaccine. J Infect Dis. 2023;228:S648\u201359. https:\/\/doi.org\/10.1093\/infdis\/jiad266.","journal-title":"J Infect Dis"},{"key":"13977_CR37","doi-asserted-by":"publisher","first-page":"S1082","DOI":"10.1093\/infdis\/jir350","volume":"204","author":"D Falzarano","year":"2011","unstructured":"Falzarano D, Feldmann F, Grolla A, Leung A, Ebihara H, Strong JE, et al. Single Immunization With a Monovalent Vesicular Stomatitis Virus\u2013Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirus. J Infect Dis. 2011;204:S1082\u20139. https:\/\/doi.org\/10.1093\/infdis\/jir350.","journal-title":"J Infect Dis"},{"key":"13977_CR38","doi-asserted-by":"publisher","first-page":"e2600","DOI":"10.1371\/journal.pntd.0002600","volume":"7","author":"CE Mire","year":"2013","unstructured":"Mire CE, Geisbert JB, Marzi A, Agans KN, Feldmann H, Geisbert TW. Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus. PLoS Negl Trop Dis. 2013;7:e2600. https:\/\/doi.org\/10.1371\/journal.pntd.0002600.","journal-title":"PLoS Negl Trop Dis"},{"key":"13977_CR39","doi-asserted-by":"publisher","first-page":"S712","DOI":"10.1093\/infdis\/jiad207","volume":"228","author":"C Woolsey","year":"2023","unstructured":"Woolsey C, Strampe J, Fenton KA, Agans KN, Martinez J, Borisevich V, et al. A Recombinant Vesicular Stomatitis Virus\u2013Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection. J Infect Dis. 2023;228:S712\u201320. https:\/\/doi.org\/10.1093\/infdis\/jiad207.","journal-title":"J Infect Dis"},{"key":"13977_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2018.06.018","volume":"49","author":"P Gilchuk","year":"2018","unstructured":"Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, et al. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity. 2018;49:363\u2013e37410. https:\/\/doi.org\/10.1016\/j.immuni.2018.06.018.","journal-title":"Immunity"},{"key":"13977_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-018-08040-w","volume":"10","author":"JM Brannan","year":"2019","unstructured":"Brannan JM, He S, Howell KA, Prugar LI, Zhu W, Vu H, et al. Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates. Nat Commun. 2019;10:105. https:\/\/doi.org\/10.1038\/s41467-018-08040-w.","journal-title":"Nat Commun"},{"key":"13977_CR42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","volume":"25","author":"ZA Bornholdt","year":"2019","unstructured":"Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host Microbe. 2019;25:49\u2013e585. https:\/\/doi.org\/10.1016\/j.chom.2018.12.005.","journal-title":"Cell Host Microbe"},{"key":"13977_CR43","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1038\/s41467-026-70464-6","volume":"17","author":"M Wang","year":"2026","unstructured":"Wang M, Zhang X, Li W, Yao Y, Li E, Zhang B, et al. A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus. Nat Commun. 2026;17:4040. https:\/\/doi.org\/10.1038\/s41467-026-70464-6.","journal-title":"Nat Commun"},{"key":"13977_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.virs.2026.03.018","volume":"41","author":"X Zhang","year":"2026","unstructured":"Zhang X, Liao Y, Liu X, Zhou J, Gao P, Dong X, et al. Nanobody targeting glycan cap confers broad orthoebolavirus neutralization. Virol Sin. 2026;41:413\u201322. https:\/\/doi.org\/10.1016\/j.virs.2026.03.018.","journal-title":"Virol Sin"},{"key":"13977_CR45","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1016\/j.cell.2021.09.035","volume":"184","author":"P Gilchuk","year":"2021","unstructured":"Gilchuk P, Murin CD, Cross RW, Ilinykh PA, Huang K, Kuzmina N, et al. Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 2021;184:5593\u2013e560718. https:\/\/doi.org\/10.1016\/j.cell.2021.09.035.","journal-title":"Cell"},{"key":"13977_CR46","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/infdis\/jiy295","volume":"218","author":"P Gilchuk","year":"2018","unstructured":"Gilchuk P, Mire CE, Geisbert JB, Agans KN, Deer DJ, Cross RW, et al. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates. J Infect Dis. 2018;218:S565\u201373. https:\/\/doi.org\/10.1093\/infdis\/jiy295.","journal-title":"J Infect Dis"},{"key":"13977_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy366","author":"J Kapetshi","year":"2018","unstructured":"Kapetshi J, Fausther-Bovendo H, Corbett C, Leung A, Ait-Ikhlef K, Nsio J, et al. Contribution of Environment Sample-Based Detection to Ebola Outbreak Management. J Infect Dis. 2018. https:\/\/doi.org\/10.1093\/infdis\/jiy366.","journal-title":"J Infect Dis"},{"key":"13977_CR48","doi-asserted-by":"publisher","first-page":"e0010167","DOI":"10.1371\/journal.pntd.0010167","volume":"16","author":"KCL Shaffer","year":"2022","unstructured":"Shaffer KCL, Hui S, Bratcher A, King LB, Mutombe R, Kavira N, et al. Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo. PLoS Negl Trop Dis. 2022;16:e0010167. https:\/\/doi.org\/10.1371\/journal.pntd.0010167.","journal-title":"PLoS Negl Trop Dis"},{"key":"13977_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1021\/acsnano.7b07021","volume":"12","author":"P Brangel","year":"2018","unstructured":"Brangel P, Sobarzo A, Parolo C, Miller BS, Howes PD, Gelkop S, et al. A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors. ACS Nano. 2018;12:63\u201373. https:\/\/doi.org\/10.1021\/acsnano.7b07021.","journal-title":"ACS Nano"},{"key":"13977_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/v11030259","volume":"11","author":"MN Rahim","year":"2019","unstructured":"Rahim MN, Wang M, Wang T, He S, Griffin BD, Kobasa D, et al. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies. Viruses. 2019;11:259. https:\/\/doi.org\/10.3390\/v11030259.","journal-title":"Viruses"},{"key":"13977_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-0716-4256-6_19","volume-title":"Marburg Virus. Methods in Molecular Biology","author":"RW Cross","year":"2025","unstructured":"Cross RW. Evaluation of Vaccines and Therapeutics Against Ebolaviruses in the Domestic Ferret. In: Banadyga L, Marzi A, editors. Marburg Virus. Methods in Molecular Biology. New York, NY: Springer US; 2025. pp. 281\u201395. https:\/\/doi.org\/10.1007\/978-1-0716-4256-6_19."},{"key":"13977_CR52","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1080\/15548627.2025.2492877","volume":"21","author":"H Huang","year":"2025","unstructured":"Huang H, Shi W, Yan H, Fan L, Lu J, Long Z, et al. Dual roles of CXCR4 (C-X-C motif chemokine receptor 4) in promoting entry of ebolavirus and targeting excessive glycoprotein for reticulophagic degradation to facilitate viral fitness. Autophagy. 2025;21:2148\u201367. https:\/\/doi.org\/10.1080\/15548627.2025.2492877.","journal-title":"Autophagy"},{"key":"13977_CR53","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/ilar\/ilab011","volume":"61","author":"Z Schiffman","year":"2020","unstructured":"Schiffman Z, Liu G, Cao W, Zhu W, Emeterio K, Qiu X, et al. The Ferret as a Model for Filovirus Pathogenesis and Countermeasure Evaluation. ILAR J. 2020;61:62\u201371. https:\/\/doi.org\/10.1093\/ilar\/ilab011.","journal-title":"ILAR J"},{"key":"13977_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/microorganisms9020213","volume":"9","author":"Z Schiffman","year":"2021","unstructured":"Schiffman Z, Yan F, He S, Tierney K, Zhu W, Emeterio K, et al. Ta\u00ef Forest Virus Does Not Cause Lethal Disease in Ferrets. Microorganisms. 2021;9:213. https:\/\/doi.org\/10.3390\/microorganisms9020213.","journal-title":"Microorganisms"},{"issue":"10","key":"13977_CR55","doi-asserted-by":"publisher","first-page":"e1013579","DOI":"10.1371\/journal.ppat.1013579","volume":"21","author":"P Fletcher","year":"2025","unstructured":"Fletcher P, O\u2019Donnell KL, Rhoderick JF, Henderson CW, Okumura A, Bushmaker T, et al. Mucosal Ta\u00ef Forest virus infection causes disease in ferrets. PLoS Pathog. 2025;21(10):e1013579. https:\/\/doi.org\/10.1371\/journal.ppat.1013579.","journal-title":"PLoS Pathog"},{"key":"13977_CR56","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3390\/v13071388","volume":"13","author":"O Escaffre","year":"2021","unstructured":"Escaffre O, Juelich TL, Neef N, Massey S, Smith J, Brasel T, et al. STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV). Viruses. 2021;13:1388. https:\/\/doi.org\/10.3390\/v13071388.","journal-title":"Viruses"},{"key":"13977_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.micpath.2019.05.010","volume":"132","author":"B Ahmad","year":"2019","unstructured":"Ahmad B, Ashfaq UA, Rahman M, Masoud MS, Yousaf MZ. Conserved B and T cell epitopes prediction of ebola virus glycoprotein for vaccine development: An immuno-informatics approach. Microb Pathog. 2019;132:243\u201353. https:\/\/doi.org\/10.1016\/j.micpath.2019.05.010.","journal-title":"Microb Pathog"},{"key":"13977_CR58","doi-asserted-by":"publisher","first-page":"111550","DOI":"10.1016\/j.compbiomed.2026.111550","volume":"204","author":"AHS Costa","year":"2026","unstructured":"Costa AHS, Gaieta EM, Albuquerque AO, Souza JS, Almeida DS, Sampaio JV, et al. Overcoming structural complexity in Galectin-3BP through an integrative computational antibody design workflow. Comput Biol Med. 2026;204:111550. https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111550.","journal-title":"Comput Biol Med"},{"key":"13977_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jtbi.2019.08.004","volume":"480","author":"C Wu","year":"2019","unstructured":"Wu C, Ren S, Wu J, Xia K. Magnus representation of genome sequences. J Theor Biol. 2019;480:104\u201311. https:\/\/doi.org\/10.1016\/j.jtbi.2019.08.004.","journal-title":"J Theor Biol"},{"key":"13977_CR60","doi-asserted-by":"publisher","first-page":"5350769","DOI":"10.1155\/2024\/5350769","volume":"2024","author":"CE Lewis","year":"2024","unstructured":"Lewis CE, Pinette MM, Lakin SM, Smith G, Fisher M, Moffat E, et al. Experimental Infection of Bundibugyo Virus in Domestic Swine Leads to Viral Shedding with Evidence of Intraspecies Transmission. Transbound Emerg Dis. 2024;2024:5350769. https:\/\/doi.org\/10.1155\/2024\/5350769.","journal-title":"Transbound Emerg Dis"},{"key":"13977_CR61","doi-asserted-by":"publisher","unstructured":"Grayo S, Camara A, Doukour\u00e9 B, Ellis I, Troupin C, Fischer K, et al. Geographic disparities in domestic pig population exposure to Ebola viruses, Guinea, 2017\u20132019. Emerg Infect Dis. 2024;30. https:\/\/doi.org\/10.3201\/eid3004.231034.","DOI":"10.3201\/eid3004.231034"},{"key":"13977_CR62","doi-asserted-by":"publisher","unstructured":"Kim JYV, Lewis CE, Pinette M, Dawson HD, Lung O, McGill J, et al. Swine model of Bundibugyo and Reston virus infection reveals a robust immune response following the infection: A multi-tissue immune profiling study. Advances in Virus Research. Elsevier; 2025. p. S0065352725000028. https:\/\/doi.org\/10.1016\/bs.aivir.2025.03.002.","DOI":"10.1016\/bs.aivir.2025.03.002"},{"key":"13977_CR63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3201\/eid2401.170401","volume":"24","author":"ED Laing","year":"2018","unstructured":"Laing ED, Mendenhall IH, Linster M, Low DHW, Chen Y, Yan L, et al. Serologic Evidence of Fruit Bat Exposure to Filoviruses, Singapore, 2011\u20132016. Emerg Infect Dis. 2018;24:114\u20137. https:\/\/doi.org\/10.3201\/eid2401.170401.","journal-title":"Emerg Infect Dis"},{"key":"13977_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s42522-025-00178-0","volume":"7","author":"MS Rekedal","year":"2025","unstructured":"Rekedal MS, Ruhs EC, Ranaivoson HC, Mittal N, Sterling SL, Kettenburg G, et al. Serologic evidence of orthomarburgviruses and an orthoebolavirus in frugivorous Malagasy bats. One Health Outlook. 2025;7:55. https:\/\/doi.org\/10.1186\/s42522-025-00178-0.","journal-title":"One Health Outlook"},{"key":"13977_CR65","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1080\/22221751.2022.2086072","volume":"11","author":"C Woolsey","year":"2022","unstructured":"Woolsey C, Fears AC, Borisevich V, Agans KN, Dobias NS, Prasad AN, et al. Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques. Emerg Microbes Infect. 2022;11:1635\u201346. https:\/\/doi.org\/10.1080\/22221751.2022.2086072.","journal-title":"Emerg Microbes Infect"},{"key":"13977_CR66","doi-asserted-by":"publisher","first-page":"682120","DOI":"10.3389\/fimmu.2021.682120","volume":"12","author":"D Paquin-Proulx","year":"2021","unstructured":"Paquin-Proulx D, Gunn BM, Alrubayyi A, Clark DV, Creegan M, Kim D, et al. Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors. Front Immunol. 2021;12:682120. https:\/\/doi.org\/10.3389\/fimmu.2021.682120.","journal-title":"Front Immunol"},{"key":"13977_CR67","doi-asserted-by":"publisher","first-page":"102375","DOI":"10.1016\/j.jaut.2019.102375","volume":"106","author":"M Rojas","year":"2020","unstructured":"Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ram\u00edrez-Santana C, Ansari AA, et al. Ebola virus disease: An emerging and re-emerging viral threat. J Autoimmun. 2020;106:102375. https:\/\/doi.org\/10.1016\/j.jaut.2019.102375.","journal-title":"J Autoimmun"},{"issue":"7","key":"13977_CR68","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373. https:\/\/doi.org\/10.7326\/M18-0850.","journal-title":"Ann Intern Med"},{"key":"13977_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1126\/science.aej0202","volume":"392","author":"K Kupferschmidt","year":"2026","unstructured":"Kupferschmidt K. Scientists play catch-up to startling Ebola outbreak. Science. 2026;392:792\u20133. https:\/\/doi.org\/10.1126\/science.aej0202.","journal-title":"Science"},{"key":"13977_CR70","doi-asserted-by":"publisher","first-page":"l14898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JA Sterne","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l14898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"13977_CR71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.10042","author":"K Schweitzer","year":"2026","unstructured":"Schweitzer K. A Rare Ebola Virus Is Spreading in the DRC\u2014Here\u2019s What to Know. JAMA. 2026. https:\/\/doi.org\/10.1001\/jama.2026.10042.","journal-title":"JAMA"},{"key":"13977_CR72","doi-asserted-by":"publisher","first-page":"e2316960121","DOI":"10.1073\/pnas.2316960121","volume":"121","author":"D Xu","year":"2024","unstructured":"Xu D, Powell AE, Utz A, Sanyal M, Do J, Patten JJ, et al. Design of universal Ebola virus vaccine candidates via immunofocusing. Proc Natl Acad Sci USA. 2024;121:e2316960121. https:\/\/doi.org\/10.1073\/pnas.2316960121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"13977_CR73","doi-asserted-by":"publisher","first-page":"eadq2496","DOI":"10.1126\/scitranslmed.adq2496","volume":"17","author":"T Mdluli","year":"2025","unstructured":"Mdluli T, Wollen-Roberts S, Merbah M, Beckman B, Li Y, Alrubayyi A, et al. Ebola virus vaccination elicits Ebola virus\u2013specific immune responses without substantial cross-reactivity to other filoviruses. Sci Transl Med. 2025;17:eadq2496. https:\/\/doi.org\/10.1126\/scitranslmed.adq2496.","journal-title":"Sci Transl Med"},{"key":"13977_CR74","doi-asserted-by":"publisher","first-page":"1742457","DOI":"10.1080\/19420862.2020.1742457","volume":"12","author":"P Fan","year":"2020","unstructured":"Fan P, Chi X, Liu G, Zhang G, Chen Z, Liu Y, et al. Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors. mAbs. 2020;12:1742457. https:\/\/doi.org\/10.1080\/19420862.2020.1742457.","journal-title":"mAbs"},{"key":"13977_CR75","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41564-018-0157-z","volume":"3","author":"AI Flyak","year":"2018","unstructured":"Flyak AI, Kuzmina N, Murin CD, Bryan C, Davidson E, Gilchuk P, et al. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2\u2013MPER region. Nat Microbiol. 2018;3:670\u20137. https:\/\/doi.org\/10.1038\/s41564-018-0157-z.","journal-title":"Nat Microbiol"},{"key":"13977_CR76","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","volume":"164","author":"AI Flyak","year":"2016","unstructured":"Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell. 2016;164:392\u2013405. https:\/\/doi.org\/10.1016\/j.cell.2015.12.022.","journal-title":"Cell"},{"key":"13977_CR77","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.26.678902","author":"MT Scotti","year":"2025","unstructured":"Scotti MT, Kelestemur E, Martin HJ, Novy B, Melo-Filho CC, De Barros RP, et al. Conserved Filovirus Proteins as Targets of Broad-Spectrum Antivirals. bioRxiv [Preprint]. 2025. https:\/\/doi.org\/10.1101\/2025.09.26.678902.","journal-title":"bioRxiv [Preprint]"},{"key":"13977_CR78","doi-asserted-by":"publisher","first-page":"e00392","DOI":"10.1128\/JVI.00392-17","volume":"91","author":"JB Ruedas","year":"2017","unstructured":"Ruedas JB, Ladner JT, Ettinger CR, Gummuluru S, Palacios G, Connor JH. Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture. J Virol. 2017;91:e00392\u201317. https:\/\/doi.org\/10.1128\/JVI.00392-17.","journal-title":"J Virol"},{"key":"13977_CR79","doi-asserted-by":"publisher","first-page":"S498","DOI":"10.1093\/infdis\/jiad228","volume":"228","author":"M Mehedi","year":"2023","unstructured":"Mehedi M, Ricklefs S, Takada A, Sturdevant D, Porcella SF, Marzi A, et al. RNA Editing as a General Trait of Ebolaviruses. J Infect Dis. 2023;228:S498\u2013507. https:\/\/doi.org\/10.1093\/infdis\/jiad228.","journal-title":"J Infect Dis"},{"key":"13977_CR80","doi-asserted-by":"publisher","first-page":"e01655","DOI":"10.1128\/spectrum.01655-21","volume":"10","author":"ZH Tan","year":"2022","unstructured":"Tan ZH, Yong KY, Shu JJ. Evolution of Viral Pathogens Follows a Linear Order. Microbiol Spectr. 2022;10:e01655\u201321. https:\/\/doi.org\/10.1128\/spectrum.01655-21.","journal-title":"Microbiol Spectr"},{"key":"13977_CR81","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/v15051075","volume":"15","author":"P Ramanathan","year":"2023","unstructured":"Ramanathan P, Tigabu B, Santos RI, Ilinykh PA, Kuzmina N, Vogel OA, et al. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24. Viruses. 2023;15:1075. https:\/\/doi.org\/10.3390\/v15051075.","journal-title":"Viruses"},{"key":"13977_CR82","doi-asserted-by":"publisher","first-page":"e01517","DOI":"10.1128\/mBio.01517-21","volume":"12","author":"C Woolsey","year":"2021","unstructured":"Woolsey C, Borisevich V, Agans KN, Fenton KA, Cross RW, Geisbert TW. Bundibugyo ebolavirus Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling. mBio. 2021;12:e01517\u201321. https:\/\/doi.org\/10.1128\/mBio.01517-21.","journal-title":"mBio"},{"key":"13977_CR83","doi-asserted-by":"publisher","first-page":"694105","DOI":"10.3389\/fimmu.2021.694105","volume":"12","author":"FB He","year":"2022","unstructured":"He FB, Khan H, Huttunen M, Kolehmainen P, Mel\u00e9n K, Maljanen S, et al. Filovirus VP24 Proteins Differentially Regulate RIG-I and MDA5-Dependent Type I and III Interferon Promoter Activation. Front Immunol. 2022;12:694105. https:\/\/doi.org\/10.3389\/fimmu.2021.694105.","journal-title":"Front Immunol"},{"key":"13977_CR84","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.virs.2023.10.004","volume":"38","author":"Z Cao","year":"2023","unstructured":"Cao Z, Liu C, Peng C, Ran Y, Yao Y, Xiao G, et al. Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication. Virol Sin. 2023;38:922\u201330. https:\/\/doi.org\/10.1016\/j.virs.2023.10.004.","journal-title":"Virol Sin"},{"key":"13977_CR85","doi-asserted-by":"publisher","unstructured":"Khan H, Tripathi L, Kolehmainen P, Lundberg R, Altan E, Heroum J, et al. VP24 matrix proteins of eight filoviruses downregulate innate immune response by inhibiting the interferon-induced pathway. J Gen Virol. 2023;104. https:\/\/doi.org\/10.1099\/jgv.0.001888.","DOI":"10.1099\/jgv.0.001888"},{"key":"13977_CR86","doi-asserted-by":"publisher","first-page":"e0201827","DOI":"10.1371\/journal.pone.0201827","volume":"13","author":"CG Albari\u00f1o","year":"2018","unstructured":"Albari\u00f1o CG, Wiggleton Guerrero L, Chakrabarti AK, Nichol ST. Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses. PLoS ONE. 2018;13:e0201827. https:\/\/doi.org\/10.1371\/journal.pone.0201827.","journal-title":"PLoS ONE"},{"key":"13977_CR87","doi-asserted-by":"publisher","first-page":"e00734","DOI":"10.1128\/mBio.00734-19","volume":"10","author":"S Landeras-Bueno","year":"2019","unstructured":"Landeras-Bueno S, Oda S, Norris MJ, Li Salie Z, Guenaga J, Wyatt RT, et al. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment. mBio. 2019;10:e00734\u201319. https:\/\/doi.org\/10.1128\/mBio.00734-19.","journal-title":"mBio"},{"key":"13977_CR88","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1016\/j.csbj.2021.09.017","volume":"19","author":"SK Gupta","year":"2021","unstructured":"Gupta SK, Ponte-Sucre A, Bencurova E, Dandekar T. An Ebola, Neisseria and Trypanosoma human protein interaction census reveals a conserved human protein cluster targeted by various human pathogens. Comput Struct Biotechnol J. 2021;19:5292\u2013308. https:\/\/doi.org\/10.1016\/j.csbj.2021.09.017.","journal-title":"Comput Struct Biotechnol J"},{"key":"13977_CR89","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1080\/15548627.2022.2031381","volume":"18","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang J, Liu X, Chai Q, Lu X, Yao X, et al. Protein disulfide isomerases (PDIs) negatively regulate ebolavirus structural glycoprotein expression in the endoplasmic reticulum (ER) via the autophagy-lysosomal pathway. Autophagy. 2022;18:2350\u201367. https:\/\/doi.org\/10.1080\/15548627.2022.2031381.","journal-title":"Autophagy"},{"key":"13977_CR90","doi-asserted-by":"publisher","first-page":"e02249","DOI":"10.1128\/mBio.02249-18","volume":"9","author":"RM DuBois","year":"2018","unstructured":"DuBois RM. Tenacious Researchers Identify a Weakness in All Ebolaviruses. mBio. 2018;9:e02249\u201318. https:\/\/doi.org\/10.1128\/mBio.02249-18.","journal-title":"mBio"},{"key":"13977_CR91","doi-asserted-by":"publisher","first-page":"RP91181","DOI":"10.7554\/eLife.91181","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang M, Wu H, Wang X, Zheng H, Feng J, et al. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus. eLife. 2024;12:RP91181. https:\/\/doi.org\/10.7554\/eLife.91181.","journal-title":"eLife"},{"key":"13977_CR92","doi-asserted-by":"publisher","first-page":"e1010518","DOI":"10.1371\/journal.ppat.1010518","volume":"18","author":"CT Schoeder","year":"2022","unstructured":"Schoeder CT, Gilchuk P, Sangha AK, Ledwitch KV, Malherbe DC, Zhang X, et al. Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathog. 2022;18:e1010518. https:\/\/doi.org\/10.1371\/journal.ppat.1010518.","journal-title":"PLoS Pathog"},{"key":"13977_CR93","doi-asserted-by":"publisher","first-page":"808047","DOI":"10.3389\/fimmu.2022.808047","volume":"12","author":"CD Murin","year":"2022","unstructured":"Murin CD, Gilchuk P, Crowe JE, Ward AB. Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development. Front Immunol. 2022;12:808047. https:\/\/doi.org\/10.3389\/fimmu.2022.808047.","journal-title":"Front Immunol"},{"key":"13977_CR94","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41594-019-0191-4","volume":"26","author":"BR West","year":"2019","unstructured":"West BR, Wec AZ, Moyer CL, Fusco ML, Ilinykh PA, Huang K, et al. Structural basis of broad ebolavirus neutralization by a human survivor antibody. Nat Struct Mol Biol. 2019;26:204\u201312. https:\/\/doi.org\/10.1038\/s41594-019-0191-4.","journal-title":"Nat Struct Mol Biol"},{"key":"13977_CR95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","volume":"25","author":"AZ Wec","year":"2019","unstructured":"Wec AZ, Bornholdt ZA, He S, Herbert AS, Goodwin E, Wirchnianski AS, et al. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection. Cell Host Microbe. 2019;25:39\u2013e485. https:\/\/doi.org\/10.1016\/j.chom.2018.12.004.","journal-title":"Cell Host Microbe"},{"key":"13977_CR96","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/v11020137","volume":"11","author":"JE Comer","year":"2019","unstructured":"Comer JE, Escaffre O, Neef N, Brasel T, Juelich TL, Smith JK, et al. Filovirus Virulence in Interferon \u03b1\/\u03b2 and \u03b3 Double Knockout Mice, and Treatment with Favipiravir. Viruses. 2019;11:137. https:\/\/doi.org\/10.3390\/v11020137.","journal-title":"Viruses"},{"key":"13977_CR97","doi-asserted-by":"publisher","first-page":"113254","DOI":"10.1016\/j.celrep.2023.113254","volume":"42","author":"RI Santos","year":"2023","unstructured":"Santos RI, Ilinykh PA, Pietzsch CA, Ronk AJ, Huang K, Kuzmina NA, et al. Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2\/tetherin. Cell Rep. 2023;42:113254. https:\/\/doi.org\/10.1016\/j.celrep.2023.113254.","journal-title":"Cell Rep"},{"key":"13977_CR98","doi-asserted-by":"publisher","first-page":"e2517814123","DOI":"10.1073\/pnas.2517814123","volume":"123","author":"J Zhang","year":"2026","unstructured":"Zhang J, Zhang X, Yao Y, Zhou J, Chen D, Shen Y, et al. Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses\u2019 exposure. Proc Natl Acad Sci USA. 2026;123:e2517814123. https:\/\/doi.org\/10.1073\/pnas.2517814123.","journal-title":"Proc Natl Acad Sci USA"},{"key":"13977_CR99","doi-asserted-by":"publisher","first-page":"e01845","DOI":"10.1128\/JVI.01845-18","volume":"93","author":"JB Kimble","year":"2019","unstructured":"Kimble JB, Malherbe DC, Meyer M, Gunn BM, Karim MM, Ilinykh PA, et al. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine. J Virol. 2019;93:e01845\u201318. https:\/\/doi.org\/10.1128\/JVI.01845-18.","journal-title":"J Virol"},{"key":"13977_CR100","doi-asserted-by":"publisher","first-page":"103363","DOI":"10.1016\/j.xpro.2024.103363","volume":"5","author":"RI Santos","year":"2024","unstructured":"Santos RI, Bukreyev A. Protocol for quantification of intercellular connection transmission in ebolavirus infections using ImageJ. STAR Protoc. 2024;5:103363. https:\/\/doi.org\/10.1016\/j.xpro.2024.103363.","journal-title":"STAR Protoc"},{"key":"13977_CR101","doi-asserted-by":"publisher","first-page":"e1010039","DOI":"10.1371\/journal.ppat.1010039","volume":"17","author":"Q Shu","year":"2021","unstructured":"Shu Q, Kenny T, Fan J, Lyon CJ, Cazares LH, Hu TY. Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. PLoS Pathog. 2021;17:e1010039. https:\/\/doi.org\/10.1371\/journal.ppat.1010039.","journal-title":"PLoS Pathog"},{"key":"13977_CR102","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jiy532","volume":"219","author":"JC Milligan","year":"2019","unstructured":"Milligan JC, Parekh DV, Fuller KM, Igarashi M, Takada A, Saphire EO. Structural Characterization of Pan-Ebolavirus Antibody 6D6 Targeting the Fusion Peptide of the Surface Glycoprotein. J Infect Dis. 2019;219:415\u20139. https:\/\/doi.org\/10.1093\/infdis\/jiy532.","journal-title":"J Infect Dis"},{"key":"13977_CR103","doi-asserted-by":"publisher","first-page":"104592","DOI":"10.1016\/j.antiviral.2019.104592","volume":"171","author":"A Pessi","year":"2019","unstructured":"Pessi A, Bixler SL, Soloveva V, Radoshitzky S, Retterer C, Kenny T, et al. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo. Antiviral Res. 2019;171:104592. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104592.","journal-title":"Antiviral Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13977-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:17Z","timestamp":1790982197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13977-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13977"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13977-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9948439\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This systematic scoping review used publicly available data and did not involve primary data collection from human participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1763"}}